RPRX Chart
- 52-Week Range: $34.87 - $46.02
- Market Capitalization: $27.31B
- Short Percentage: 0%
- Target Price: $52.00
- Shares Outstanding: 435.32M
- Next Earnings: Nov 30
Catalysts
CategoryCatalyst
Earnings
RPRX released their earnings report for the previous quarter and provided guidance on the current and upcoming quarters.
News and Press Releases
- Updated Guidance And Royalty Pharma Financing Demolish Short Thesis For BioCryst PharmaceuticalsSeeking Alpha | February 7th
- BioCryst Shares Gain As Royalty Pharma Buys Additional Interests In BCX9930, OrladeyoBenzinga | November 22nd
- Warren Buffett Buys 2 Stocks, Adds to Chevron Stake in 3rd QuarterGuruFocus | November 15th
- Warren Buffett's Berkshire Hathaway reveals new bets on Floor & Decor and Royalty PharmaBusiness Insider | November 15th
Company Info
Website: https://www.royaltypharma.com
Address: 110 East 59th Street, New York, NY, United States, 10022
Sector: Healthcare
Industry: Biotechnology
Full time employees: N/A
Address: 110 East 59th Street, New York, NY, United States, 10022
Sector: Healthcare
Industry: Biotechnology
Full time employees: N/A
$RPRX going down
$RPRX more shorts the better idc
$RPRX the price is wrong
$RPRX very nice
$RPRX good place to average up
$RPRX not worrying
$RPRX this sell-off is meh.
$RPRX Shorts are calling in all the favors